InvestorsHub Logo

Jimmy Joe

02/08/16 3:09 PM

#182924 RE: mightymk #182918

the FDA can delay this for years till every thing is perfect in place



Mike... FDA cannot afford to do that even by their own admission.
The FDA has put itself in a corner so to speak.

If Elites technology is safe.... which it is...if Elites technology works effectively to counter prescription opioid abuse...which it does..... How can the FDA afford NOT to approve this when even the FDA admits the problem is beyond the scope of out of control?

The FDA need is now. Not years from now. If the FDA balks at approving something that can begin to put an end to this problem there will be political fallout of major proportions.

The public outcry will be the likes of which we have not seen in quite a while.

People are dying on pharmaceutical grade heroin and the problem is getting worse not better.

Just my opinion.

no2koolaid

02/08/16 3:35 PM

#182933 RE: mightymk #182918

As Simon & Garfunkel sang, "A man sees what he wants to see and disregards the rest." They actually borrowed that thought from Francis Bacon, but the point is well made. Still, it is not merely that, it is about experience. We cannot expect to see or understand what others do when we lack the same level of experience and education. That is why we have experts. So, allow me to share my expertise and make three observations...

I do not think it would be an offer between $8-10 Billion. Too high. I do think it would be in a range reflective of the prices paid for comparable firms, with comparability based on a range of things; not merely product similarities - kind of like houses. Simply being in the same neighborhood does not mean the house is the same size or has the same amenities and, thus, is worth the same. The art of the deal is determining and negotiating a price based on the specifics.

The number of shares Nasrat holds does not matter to a formal offer to acquire Elite. Nor does it afford him a different position for which to accept or reject the offer, that belongs to the BOD and, though Nasrat is part of it, his share holdings do not alter his fiduciary responsibility to make the best deal he can for ALL shareholders.

I agree that I would not say nothing or no one can stop Elite. But, I never took that as a literal analysis. It is merely evocative of the substantial evidence in support of Elite's pending success.

Couch

02/08/16 5:57 PM

#182948 RE: mightymk #182918

Nasrat has over 152 million shares - how do you propose the man sells those shares without the PPS tanking should he not sell the company? He's been in the Big Leagues for 30 years - you think he didn't think this through before putting his money - $1 million UNSECURED dollars on the line - and buying another 700,000 shares thereafter of his own money.

NOBODY will stop us huh - well tell me again what Nasrat did at Actavis prior to his retiring from this company?? How often do you suppose he had ongoing contact with the FDA.

Positive phase 3 data tells me Nasrat already knows we are in a different league and his buying shares at .31 tells me so. Next

richme

02/08/16 6:13 PM

#182951 RE: mightymk #182918

How about an earnings report? Is that possible anytime soon?